Jamjoom Pharma listed on Everest ransomware leak site

• Ransomware group: Everest
• Country: Saudi Arabia
• Sector: Healthcare
• Announcement date: May 2, 2025

The ransomware group known as Everest has listed Jamjoom Pharma on its leak site, alleging that the organization has been the victim of a data breach. This announcement, made by the threat actor, marks a new development in the ongoing landscape of targeted cyberattacks against critical infrastructure and specialized industries.

The alleged attack and claim

According to the announcement published on the Everest leak site on May 2, 2025, the group claims to have targeted Jamjoom Pharma. The group alleges that the institution was subjected to a cyberattack on May 1, 2025. Through their public post, the threat actors claim to have successfully obtained the institution's data, and they have used their dedicated leak site to publicize this situation to the world.

Ransomware attacks of this nature often follow a pattern of double extortion. In such scenarios, threat actors do not merely encrypt an organization's systems to disrupt operations; they also focus on exfiltrating sensitive information. The goal of this secondary tactic is to pressure the victim into paying a ransom by threatening to release the stolen data publicly. By hosting a leak site, these groups create a public stage to shame their targets and increase the perceived urgency of the situation.

Data involved in the claim

Regarding the specific content of the alleged breach, the group has not provided any details or sample files regarding the nature of the data they claim to have stolen. The listing names no specific data types or categories of information.

About Jamjoom Pharma

Jamjoom Pharma is a leading pharmaceutical company that maintains a significant presence in the Middle East and Africa region. The company is actively engaged in the manufacturing and marketing of medicines across various therapeutic areas. Headquartered in Jeddah, Saudi Arabia, the organization plays a key role in the regional healthcare supply chain.

Analysis and potential implications

Considering the past activities of the Everest group, there is a possibility that the institution's sensitive data has been compromised. When a breach occurs, it can lead to several secondary risks. For the employees and customers of the affected organization, the theft of sensitive information could potentially lead to identity theft or the execution of highly targeted phishing attacks.

Because Jamjoom Pharma operates within the healthcare sector, a potential breach could trigger significant legal processes under local data protection regulations. The regulatory landscape for healthcare providers is often stringent due to the sensitive nature of the information handled by these entities. Furthermore, the group's specific focus on data theft and extortion may create substantial pressure on the institution's ability to maintain operational continuity.

While public information regarding the Everest group remains limited, their ability to target large-scale organizations highlights the ongoing risks faced by the pharmaceutical industry. Organizations in this sector typically focus on robust defensive measures to mitigate such risks, such as implementing strict access controls, maintaining comprehensive logging, and ensuring regular offline backups. Protecting the integrity of the supply chain and patient-related data remains a primary concern for healthcare-related entities globally.